Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2024-03-26 00:00:00 ET · period of report 2024-03-23 · accession 0001214659-24-005215 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-26 | 2024-03-23 | CPIX | Herman James L | VP, Chief Compliance Office | F - Tax | $1.81 | -1,186 | 38.3K | -3% | -$2,147 |
| D | 2024-03-26 | 2024-03-25 | CPIX | Herman James L | VP, Chief Compliance Office | A - Grant | $1.71 | +4,000 | 16.0K | +33% | +$6,840 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-23 | F | D | 1,186 | $1.81 | 38,255 | D | — | — | (F1) This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares. |
| 2 | Derivative | Options (right to buy) | 2024-03-25 | A | A | 4,000 | $1.71 | 16,000 | D | $1.71 · 2028-03-25 to 2034-03-25 | 4,000 Common Stock |